These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 25440277)

  • 1. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules.
    Cho JH; Choi YS; Kim J; Kim HK; Zo JI; Shim YM
    Ann Thorac Surg; 2015 Jan; 99(1):218-22. PubMed ID: 25440277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    Chest; 2014 Jan; 145(1):66-71. PubMed ID: 24551879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience.
    Yamaguchi M; Furuya A; Edagawa M; Taguchi K; Shimamatsu S; Toyokawa G; Toyozawa R; Nosaki K; Hirai F; Seto T; Takenoyama M; Ichinose Y
    Surg Oncol; 2015 Sep; 24(3):258-63. PubMed ID: 26298200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Management of Multifocal Ground-Glass Opacities of the Lung: Correlation of Clinicopathologic and Radiologic Findings.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Thorac Cardiovasc Surg; 2017 Mar; 65(2):142-149. PubMed ID: 26902328
    [No Abstract]   [Full Text] [Related]  

  • 5. Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinoma.
    Gao RW; Berry MF; Kunder CA; Khuong AA; Wakelee H; Neal JW; Backhus LM; Shrager JB
    J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2092-2099.e2. PubMed ID: 28863952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors of Recurrence in Patients With Clinical Stage IA Adenocarcinoma Presented as Ground-Glass Nodule.
    Su H; Dai C; Xie H; Ren Y; She Y; Kadeer X; Xie D; Zheng H; Jiang G; Chen C
    Clin Lung Cancer; 2018 Sep; 19(5):e609-e617. PubMed ID: 29803575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1100-1108. PubMed ID: 28629842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of clinical outcomes in patients with and without a preoperative tissue diagnosis in the persistent malignant-looking, ground-glass-opacity nodules.
    Choi SH; Chae EJ; Shin SY; Kim EY; Kim JE; Lee HJ; Oh SY; Lee SM
    Medicine (Baltimore); 2016 Aug; 95(34):e4359. PubMed ID: 27559945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma.
    Miyoshi T; Aokage K; Katsumata S; Tane K; Ishii G; Tsuboi M
    Ann Thorac Surg; 2019 Jul; 108(1):249-255. PubMed ID: 30876742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-Year Follow-Up of Lung Cancer Patients with Resected Stage IA Invasive Non-Small Cell Lung Cancer.
    Li X; Fan F; Yang Z; Huang Q; Fu F; Zhang Y; Chen H
    Ann Surg Oncol; 2024 Sep; 31(9):5729-5737. PubMed ID: 38888859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical Outcomes of Lobectomy Versus Limited Resection for Clinical Stage I Ground-Glass Opacity Lung Adenocarcinoma 2 Centimeters or Smaller.
    Zhang C; He Z; Cheng J; Cao J; Hu J
    Clin Lung Cancer; 2021 Mar; 22(2):e160-e168. PubMed ID: 33160898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?
    Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K
    Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited resection trial for pulmonary ground-glass opacity nodules: case selection based on high-resolution computed tomography-interim results.
    Yoshida J; Ishii G; Hishida T; Aokage K; Tsuboi M; Ito H; Yokose T; Nakayama H; Yamada K; Nagai K
    Jpn J Clin Oncol; 2015 Jul; 45(7):677-81. PubMed ID: 25900903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Nodule Density in Women With Sublobar Resection for Stage IA Adenocarcinoma.
    Phillips WW; Gill RR; Mazzola E; Armitage JR; de Forcrand C; Colson YL; Gibney BC
    Ann Thorac Surg; 2021 Oct; 112(4):1067-1075. PubMed ID: 33181131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of positron emission tomography and high-resolution computed tomography in clinical stage IA lung adenocarcinoma.
    Uehara H; Tsutani Y; Okumura S; Nakayama H; Adachi S; Yoshimura M; Miyata Y; Okada M
    Ann Thorac Surg; 2013 Dec; 96(6):1958-65. PubMed ID: 24021765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma.
    Kim HK; Choi YS; Kim J; Shim YM; Lee KS; Kim K
    J Thorac Oncol; 2010 Feb; 5(2):206-10. PubMed ID: 19901852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Proposal for Restaging of Invasive Lung Adenocarcinoma Manifesting as Pure Ground Glass Opacity.
    Mao R; She Y; Zhu E; Chen D; Dai C; Wu C; Xie H; Zhu H; Fei K; Chen C
    Ann Thorac Surg; 2019 May; 107(5):1523-1531. PubMed ID: 30576635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.
    Li Z; Ye B; Bao M; Xu B; Chen Q; Liu S; Han Y; Peng M; Lin Z; Li J; Zhu W; Lin Q; Xiong L
    PLoS One; 2015; 10(9):e0136616. PubMed ID: 26339917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Objective definition and measurement method of ground-glass opacity for planning limited resection in patients with clinical stage IA adenocarcinoma of the lung.
    Matsuguma H; Nakahara R; Anraku M; Kondo T; Tsuura Y; Kamiyama Y; Mori K; Yokoi K
    Eur J Cardiothorac Surg; 2004 Jun; 25(6):1102-6. PubMed ID: 15145016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.